back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2016-02-15 Tx date 2015-12-31 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Champagne, Monique
5 - Senior Officer of Issuer
Holder: Sunlife (Indirect Ownership)
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$20,542
+60,596 vol $0.339 each |
322,207 | |
| Filed 2015-12-04 Tx date 2015-12-02 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Champagne, Monique
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$990.00
+3,000 vol $0.33 each |
12,000 | |
| Filed 2015-12-03 Tx date 2015-12-02 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Champagne, Monique
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,145
+6,500 vol $0.33 each |
9,000 | |
| Filed 2015-12-03 Tx date 2015-12-02 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Champagne, Monique
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$812.50
+2,500 vol $0.325 each |
2,500 | |
| Filed 2015-12-03 Tx date 2010-09-09 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Champagne, Monique
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-09-14 Tx date 2015-09-09 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Champagne, Monique
5 - Senior Officer of Issuer
Direct Ownership
|
Options common
50 - Grant of options
|
$147,000
+350,000 vol $0.42 each |
||
| Filed 2015-09-14 Tx date 2015-09-09 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Champagne, Monique
5 - Senior Officer of Issuer
Direct Ownership
|
Options common
50 - Grant of options
|
$145,250
+350,000 vol $0.415 each |
610,000 |